Trademark Opposition: Shanghai Zhenglang Technology Co., Ltd. v. Mavericks Link Limited

USPTO Trademark Trial and Appeal Board (TTAB) instituted Opposition No. 91306403 filed by Shanghai Zhenglang Technology Co., Ltd. against Mavericks Link Limited regarding trademark application matters. The opposition proceeding initiates formal adjudication of competing trademark interests before the TTAB administrative tribunal.

CFTC Awards $4M to Two Whistleblowers for Enforcement

The CFTC announced nearly $4 million in awards to two whistleblowers who provided information leading to successful enforcement of a covered action. One whistleblower reported earlier and received a higher award based on timeliness factors among other considerations. The violations related to market integrity and CFTC investigation integrity. Since issuing its first award in 2014, the CFTC has granted approximately $390 million in whistleblower awards associated with enforcement actions resulting in over $3.2 billion in monetary sanctions.

CFTC Awards Over $1 Million to Whistleblower Who Aided a Digital Assets-Related Investigation

The Commodity Futures Trading Commission announced a whistleblower award of over $1 million to an individual who provided significant information and assistance that led the CFTC to bring an enforcement action connected to digital asset markets. The CFTC based its enforcement action on whistleblower-provided information about improper trading that was previously unknown to the agency. Since issuing its first award in 2014, the CFTC has granted whistleblower awards totaling approximately $380 million associated with enforcement actions resulting in nearly $3.2 billion in monetary sanctions.

CFTC Announces Four Whistleblower Awards Totaling $4.5 Million to Seven Recipients

The CFTC announced four orders granting whistleblower awards totaling approximately $4.5 million to seven whistleblowers, marking the most awards issued on a single day in the program's history. The awards recognize whistleblowers who provided information leading to successful enforcement actions, including victims of fraud, market participants, and employees who reported violations internally after 120 days without remedial action.

CFTC Awards Approximately $700,000 to Whistleblower

The CFTC announced a whistleblower award of approximately $700,000 to an individual whose information prompted the agency to open an investigation and described misconduct that appeared in the enforcement order. The whistleblower provided substantial assistance that helped conserve Commission resources, though the award was reduced due to unreasonable delay in reporting and whistleblower culpability. Since 2014, the CFTC has granted awards totaling approximately $390 million associated with enforcement actions resulting in over $3.2 billion in monetary sanctions.

CFTC Awards Over $4 Million to Insider Whistleblower

The Commodity Futures Trading Commission announced an award of over $4 million to an insider whistleblower who provided information that enabled the Division of Enforcement to open an investigation into ongoing misconduct involving complex products and transactions. The whistleblower reported failures to comply with CFTC rules protecting against fraudulent, deceptive, and manipulative practices, and cooperated throughout the investigation.

Composition Comprising Lactic Acid Bacteria Derived from Green Tea for Improving Liver Function

USPTO granted patent US12594310B2 to AMOREPACIFIC CORPORATION on April 7, 2026, covering a method for improving hepatic function using a composition derived from green tea-derived Lactiplantibacillus plantarum strain. The patent includes 6 claims and covers the strain, culture, lysate, and extracts thereof.

Method for treating liver cirrhosis using mesenchymal stem cell composition

The USPTO granted patent US12594304B2 to GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD. for a method of treating liver cirrhosis using a composition comprising mesenchymal stem cells, extracellular vesicles produced by mesenchymal stem cells, and growth factors. The patent contains 15 claims and is classified under CPC codes A61K 35/28, A61K 9/0019, and A61P 1/16.

Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells

The USPTO granted patent US12594306B2 to the Regents of the University of Colorado on April 7, 2026. The patent covers methods and compositions for identifying, sorting, and separating stem cell-derived pancreatic beta cells using the cell surface protein ENTPD3 (CD39L3) for diabetes treatment applications. The patent includes 13 claims and has a filing date of March 25, 2022.

Methods of preparing a postbiotic composition

USPTO granted patent US12594308B2 to Science Power SRL covering methods of preparing postbiotic compositions through multiple separate microbial fermentations. The patent, based on Application No. 18909568 filed October 8, 2024, includes 15 claims and lists Federica Nigro as the inventor. The composition may be produced via parallel or sequential fermentation steps.